CD27 and neoplasm: We previously demonstrated that stimulation of the TNFRSF member, CD27 on T cells, promotes activation of bystander myeloid cells leading to increased antibody-dependent cellular phagocytosis (ADCP), in the context of a second tumour-targeting mAb16.